Mesenchymal stem cells release miR-100 in exosomes, which modulate mTOR/HIFα to decrease VEGF expression and secretion by tumor cells in the breast cancer TME resulting in decreased angiogenesis [134,135]. Here, VEGFA is linked to breast carcinoma.